A global medical products company specializing in hospital and renal care equipment, pharmaceuticals, and biotechnology solutions. Investors monitor Baxter for its steady cash flows in essential healthcare markets and its exposure to long-term demographic trends in chronic disease treatment.
3 members of Congress have disclosed 6 trades in Baxter International Inc. (BAX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 3 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2003-06-09 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2003-03-10 | Richard L. Hanna | sell | $1K – $15K |
| 2003-03-09 | Lamar Smith | buy | $1K – $15K |
| 2002-01-10 | Lamar Smith | sell | $1K – $15K |
| 2001-06-10 | Richard L. Hanna | sell | $1K – $15K |
| 2001-06-09 | MICHAEL T. MCCAUL | buy | $1K – $15K |